Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Showing results (41-50 of 338) with videos related to

Pageof 34
Sort By:
Drugs|January 1, 1988
Haemodynamic effects of urapidil in arterial hypertension and congestive heart failureF H Messerli
Cardiovascular Drugs and Therapy|July 4, 1998
Nifedipine after acute myocardial infarction--sola dosis facit venenum: only the dose determines the harmF H Messerli
The New England Journal of Medicine|July 30, 1981
The antihypertensive effect of jogging--a hypothesisF H Messerli
Journal of Cardiovascular Pharmacology|January 1, 1984
Pathophysiologic clinical clues in essential hypertension: a rationale for initial therapyF H Messerli
The American Journal of Medicine|May 17, 1991
Left ventricular hypertrophy: impact of calcium channel blocker therapyF H Messerli
The American Journal of Cardiology|October 1, 1990
"Cardioprotection"--not all calcium antagonists are created equalF H Messerli
Journal of the National Medical Association|January 1, 1989
Management of essential hypertension in the black patient: profiling as the initial approach to treatmentF H Messerli
The American Journal of Medicine|May 1, 1986
Osler's maneuver, pseudohypertension, and true hypertension in the elderlyF H Messerli
The New England Journal of Medicine|February 6, 1986
Cardiopathy of obesity--a not-so-Victorian diseaseF H Messerli
International Journal of Cardiology|April 1, 1983
Cardiovascular adaptations to obesity and arterial hypertension: detrimental or beneficial?F H Messerli
Pageof 34

Showing results (41-50 of 338) with videos related to

Sort By:
Pageof 34
Drugs|January 1, 1988
Haemodynamic effects of urapidil in arterial hypertension and congestive heart failureF H Messerli
Cardiovascular Drugs and Therapy|July 4, 1998
Nifedipine after acute myocardial infarction--sola dosis facit venenum: only the dose determines the harmF H Messerli
The New England Journal of Medicine|July 30, 1981
The antihypertensive effect of jogging--a hypothesisF H Messerli
Journal of Cardiovascular Pharmacology|January 1, 1984
Pathophysiologic clinical clues in essential hypertension: a rationale for initial therapyF H Messerli
The American Journal of Medicine|May 17, 1991
Left ventricular hypertrophy: impact of calcium channel blocker therapyF H Messerli
The American Journal of Cardiology|October 1, 1990
"Cardioprotection"--not all calcium antagonists are created equalF H Messerli
Journal of the National Medical Association|January 1, 1989
Management of essential hypertension in the black patient: profiling as the initial approach to treatmentF H Messerli
The American Journal of Medicine|May 1, 1986
Osler's maneuver, pseudohypertension, and true hypertension in the elderlyF H Messerli
The New England Journal of Medicine|February 6, 1986
Cardiopathy of obesity--a not-so-Victorian diseaseF H Messerli
International Journal of Cardiology|April 1, 1983
Cardiovascular adaptations to obesity and arterial hypertension: detrimental or beneficial?F H Messerli
Pageof 34